Free Trial

Rapt Therapeutics (RAPT) Earnings Date, Estimates & Call Transcripts

Rapt Therapeutics logo
$11.46 -0.19 (-1.63%)
Closing price 08/28/2025 04:00 PM Eastern
Extended Trading
$11.46 0.00 (0.00%)
As of 07:28 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Rapt Therapeutics Earnings Summary

Rapt Therapeutics announced Q2 2025 earnings on August 7, 2025, reporting an EPS of -$0.65, which missed analysts' consensus estimates of -$0.61 by $0.04. With a trailing EPS of -$14.17, Rapt Therapeutics' earnings are expected to grow next year, from ($2.14) to ($1.35) per share.

Upcoming Q3
Earnings Date
Nov. 11Before Market OpensEstimated
Consensus EPS
(Aug. 7)
-$0.61
Actual EPS
(Aug. 7)
-$0.65 Missed By -$0.04

Q2 2025 Earnings Resources

RAPT Upcoming Earnings

Rapt Therapeutics' next earnings date is estimated for Tuesday, November 11, 2025, based on past reporting schedules.

Get Rapt Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Rapt Therapeutics and other key companies, straight to your inbox.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

RAPT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Rapt Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$1.28-$1.28-$1.28
Q2 20252-$0.67-$0.66-$0.67
Q3 20252-$1.15-$0.76-$0.96
Q4 20252-$0.95-$0.95-$0.95

Rapt Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/11/2025
(Estimated)
--------
8/7/2025Q2 2025-$0.61-$0.65 -$0.04-$0.65--
5/8/2025Q1 2025-$2.48-$0.64+$1.84-$0.08--
3/6/2025Q4 2024-$3.60-$9.12 -$5.52-$1.14--
11/12/2024--$4.48-$3.76+$0.72-$0.47--
8/8/2024--$5.92-$5.68+$0.24-$0.71--
5/9/2024Q1 2024-$6.24-$6.32 -$0.08-$0.79--
3/7/2024Q4 2023-$6.80-$6.40+$0.40-$0.80--
11/13/2023Q3 2023-$6.00-$6.56 -$0.56-$0.82--

Rapt Therapeutics Earnings - Frequently Asked Questions

Rapt Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 11th, 2025 based off last year's report dates. Learn more on RAPT's earnings history.

In the previous quarter, Rapt Therapeutics (NASDAQ:RAPT) missed the analysts' consensus estimate of ($0.61) by $0.04 with a reported earnings per share (EPS) of ($0.65). Learn more on analysts' earnings estimate vs. RAPT's actual earnings.

Rapt Therapeutics (NASDAQ:RAPT) has a recorded net income of -$129.87 million. RAPT has generated -$14.17 earnings per share over the last four quarters.

Rapt Therapeutics' earnings are expected to grow from ($2.14) per share to ($1.35) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:RAPT) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners